Based on the mechanism of SARS-CoV-2 invasion, a modified form of soluble ACE2, called human recombinant soluble ACE2 (hrsACE2), that competitively binds to the virus would be beneficial for the treatment of COVID-19 [95]. Here, ACE2 is linked to COVID-19.